Evidence map›Paper›PMID 30241257›Full record

ArticleJournal of global oncology2018

Impact of GI Tumor Board on Patient Management and Adherence to Guidelines.

Haneen A AlFarhan, Ghada F Algwaiz, Hajer A Alzahrani, Roaa S Alsuhaibani, Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, Abdul Rahman Jazieh

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Haneen A AlFarhanHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Ghada F AlgwaizHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Hajer A AlzahraniHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Roaa S AlsuhaibaniHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Ashwaq AlolayanHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Nafisa AbdelhafizHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Yosra AliHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Sami BoghdadlyHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Abdul Rahman JaziehHaneen A. AlFarhan, Ghada F. Algwaiz, Hajer A. Alzahrani, and Roaa S. Alsuhaibani, King Saud bin Abdulaziz University for Health Sciences; Ashwaq Alolayan, Nafisa Abdelhafiz, Yosra Ali, Sami Boghdadly, and Abdul Rahman Jazieh, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences · SABristol-Myers Squibb (Germany) · DEAstraZeneca (Brazil) · BRKing Abdulaziz Medical City · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs the burden of cancer on the population and the health care system continues to increase with more complicated treatment options, the need for multidisciplinary teams to be as efficient as possible becomes more vital. Our study aimed to evaluate the consistency of GI Tumor Board (GI TB) recommendations with international guidelines, the adherence of physicians involved in patient care to TB recommendations, and the impact on the management of patients.

methodsA prospective cohort study was conducted from January to June 2016 at our institution, which is a major tertiary hospital that provides comprehensive cancer care. All cases presented at the GI TB during this period were included. Data regarding adherence to National Comprehensive Cancer Network guidelines, adherence to TB recommendations, and changes made to the management of patients were collected weekly from the GI TB in a data collection form.

resultsOf the 104 patients included, 57 (55%) were males and the median age was 58 (16 to 85) years. Colorectal cancer was the most common diagnosis, in 65 patients (63%). Nearly one-half of cases (45%) were stage IV cancers. Starting new treatment was recommended for 72 patients (69%). Further investigations were requested for 15 patients (14%). For imaging, 24 recommendations (23%) were made. Adherence to National Comprehensive Cancer Network guidelines was observed in 97% of total recommendations. New findings were found in pathology (11%), radiology (13%), and staging (4%). Management plans were changed in 37 cases (36%). Over a 3-month period after presentation to the GI TB, most of the recommendations (87%) were performed.

conclusionA multidisciplinary tumor board enhances the adherence to guidelines and has an impact on patient management in approximately one-third of patients. Among physicians, adherence to recommendations of the TB was high.

Indexed as

AdolescentAdultAgedAged, 80 and overCohort StudiesColorectal NeoplasmsFemaleGastrointestinal NeoplasmsGastrointestinal TractGuidelines as TopicHumansMaleMiddle AgedYoung Adult

Identifiers

PMID30241257
PMCPMC6223466
OpenAlexW2789961190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.